A Study for Monthly Methoxy Polyethylene Glycol-Epoetin Beta Treatment in Patients With Chronic Renal Anaemia
Status:
Terminated
Trial end date:
2011-09-30
Target enrollment:
Participant gender:
Summary
This open-label single-arm study will evaluate the efficacy, safety and tolerability of
methoxy polyethylene glycol epoetin beta on long-term maintenance of haemoglobin levels in
patients with chronic renal anaemia. Patients will receive methoxy polyethylene
glycol-epoetin beta intravenously once monthly at initial doses of either 120 micrograms or
200 micrograms or 360 micrograms in the titration phase of 16 weeks with a potential dose
adjustment in the evaluation phase of 8 weeks. The anticipated time on study treatment is 24
weeks. The target sample size is 50-100 patients.